Daniel Ortega Ponce

Daniel Ortega Ponce is an Assistant Research Professor (tenure track) at IMDEA Nanociencia, a leading research institute in Spain focused on nanoscience and nanotechnology. He is affiliated with the CNB-IMDEA Nanociencia Associated Unit and holds an honorary position at the UCL Institute of Biomedical Engineering, University College London. His research is centered on the development and application of magnetic nanoparticles for biomedical purposes.

His research interests lie at the intersection of nanomagnetism and biomedicine. He specializes in magnetocaloric nanomaterials and magnetic hyperthermia, with applications in cancer therapy, cardiovascular disease, drug delivery, and molecular detection. His work includes the development of in vivo diagnostic tools such as infrared luminescence transient nanothermometry for early tumor detection and treatment planning software for clinical magnetic hyperthermia.

The recent publications highlight a strong focus on translational nanomedicine, combining advanced magnetic materials with biological systems for therapeutic and diagnostic applications. Key themes include targeted cell delivery, in vivo thermal sensing, and magnetic nanoparticle-based theranostics, primarily applied to oncology and regenerative medicine.

Scientific Awards:

• Intraeuropean Marie Curie Postdoctoral Fellowship

Advising and Grants: While no students are listed, Dr. Ortega leads an active research group focused on hyperthermia, indicating mentorship roles. His career has been supported by prestigious grants including a Marie Curie action and positions at internationally recognized institutions such as UCL and The Royal Institution. His ongoing work at IMDEA Nanociencia suggests sustained funding in nanomedicine and magnetic materials research.

Labs and Teams: Dr. Ortega is part of the research staff at IMDEA Nanociencia and belongs to the CNB-IMDEA Nanociencia Associated Unit. His group's webpage is dedicated to hyperthermia research, indicating leadership in a specialized team developing magnetic nanoparticle therapies. He has collaborated extensively with institutions in Spain, the UK, and Japan, reflecting a strong international research network.